Document text
From: Smith, Michael (CBER)
Sent: Tuesday, August 17, 2021 6:11 PM
To: Harkins Tull, Elisa <[email protected]>
Cc: Naik, Ramachandra <[email protected]>; Gottschalk, Laura
<[email protected]>; Aghajani Memar, Neda <[email protected]>; Devlin,
Carmel M <[email protected]>
Subject: STN 125742.0: 4th set of PI labeling comments
Elisa,
I attached the 4th set of comments on the Package Insert (PI). Please e- mail us the
further revised PI (both Word tracked- changes and Word annotated) by 12:00 PM
Wednesday, August 18, 2021, and follow up with a submission to the BLA.
Regards,
Mike
- Please confirm receipt of this e -mail and let us know if you have any
questions.
Mike Smith, Ph.D.
Captain, USPHS
Senior Regulatory Review Officer
Food and Drug Administration
Center for Biologics Evaluation & Research
Office of Vaccines Research & Review
Division of Vaccines and Related Products Applications Tel: 301- 796-2640
[email protected]
THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS
ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM DISCLOSURE UNDER LAW. If you are not the addressee, or a
person authorized to deliver the document to the addressee, you are hereby
notified that any review, disclo sure, dissemination, copying, or other action
based on the content of this communication is not authorized. If you have
received this document in error, please immediately notify the sender
immediately by e- mail or phone.
FDA-CBER-2021-5683-1024800